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Abstract
Background: Absorption of water and Na+ in descending colonic crypts is dependent on the
barrier function of the surrounding myofibroblastic pericryptal sheath. Here the effects of high and
low Na+ diets and exposure to whole body ionising radiation on the growth and activation of the
descending colonic pericryptal myofibroblasts are evaluated. In addition the effect of a post-
irradiation treatment with the angiotensin converting enzyme inhibitor Captopril was investigated.
Methods: The levels of Angiotensin II type 1 receptor (AT1), ACE, collagen type IV, transforming
growth factor-β  type 1 receptor (TGF-β R1), OB cadherin and α -smooth muscle actin in both
descending colon and caecum were evaluated, using immunocytochemistry and confocal
microscopy, in rats fed on high and low Na+ diets (LS). These parameters were also determined
during 3 months post-irradiation with 8Gy from a 60Co source in the presence and absence of the
angiotensin converting enzyme inhibitor, Captopril.
Results: Increases in AT1 receptor (135.6% ± 18.3, P < 0.001); ACE (70.1% ± 13.1, P < 0.001);
collagen type IV (49.6% ± 15.3, P < 0.001); TGF-β 1 receptors (291.0% ± 26.5, P < 0.001); OB-
cadherin (26.3% ± 13.8, P < 0.05) and α -smooth muscle actin (82.5% ± 12.4, P < 0.001) were
observed in the pericryptal myofibroblasts of the descending colon after LS diet. There are also
increases in AT1 receptor and TGF-β 1 receptor, smooth muscle actin and collagen type IV after
irradiation. Captopril reduced all these effects of irradiation on the pericryptal sheath and also
decreased the amount of collagen and smooth muscle actin in control rats (P < 0.001).
Conclusions: These results demonstrate an activation of descending colonic myofibroblasts to
trophic stimuli, or irradiation, which can be attenuated by Captopril, indicative of local trophic
control by angiotensin II and TGF-β  release.
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Background
It has become clear that colonic absorptive function de-
pends not only on crypt luminal cells but also on the my-
ofibroblast cells of the surrounding pericryptal sheath.
The main difference between the response of myofibrob-
lasts in descending colon pericryptal sheath from other
tissues is the significant barrier to diffusion of macromol-
ecules and NaCI in the colon generated by the fibronexus
i.e. the multiple connections between cells and extracellu-
lar matrix [1,2].
The development of the barrier function is evident from
the layered structure of the myofibroblasts surrounding
the crypt as opposed to an open stellate conformation in
the deeper layers of the lamina propria [3]. The pericryptal
layers are held together by OB-cadherin and E-cadherin
and both these intercellular adhesion molecules are re-
quired for anchoring to cytoskeletal elements (smooth
muscle actin) [4]. The evidence that the sheath acts as a
functional barrier to macromolecules like dextran is dem-
onstrated by the accumulation of these macromolecules
both in vitro and in vivo in the pericryptal sheaths of rat
and murine descending crypts [5,6]. We also have recently
demonstrated in vivo that a much higher Na+ concentra-
tion exists within the sheath than in the lamina propria.
This indicates that the sheath retards ion equilibration be-
tween the space within the sheath and the lamina propria.
Unlike the pericryptal sheath, which is not penetrated by
capillaries, the lamina propria is directly irrigated by cap-
illary flow [6].
A number of factors have been shown to influence colonic
Na+ absorption such as low/high Na+ diet, circulating al-
dosterone and ionising radiation exposure. Whilst epithe-
lial cell Na/K-ATPase activity for example may be
markedly altered by such factors the myofibroblasts may
also be considered responsive elements.
Low Na+(LS) diet.
The distal colon of rat, rabbit and human responds to al-
dosterone by generating amiloride- or benzamil-sensitive
Na+ conductance channels [7–11]. The proximal colon
differs from the distal colon in that it does not have ami-
loride-sensitive Na+ conductance channels [4]. Instead,
electroneutral NaCI absorption is mainly accomplished
by dual Na+-H+ and Cl- bicarbonate exchanges [7,8,12–
16]. The passive permeability to NaCI and water is higher
in the proximal than the distal colon [12,15].
The view that a low Na+ (LS) diet or aldosterone affects co-
lonic absorptive function, solely by increasing the expres-
sion of the amiloride-sensitive Na+ conductance channel
(ENaC) and (Na+ - K+ ATPase, has been questioned [17–
19]. Findings with mineraloreceptor knockout mice indi-
cate that control of Na+ absorption is not achieved by
transcriptional control alone [17]. There is, however,
some uncertainty about whether or not the early aldoster-
one effect causes transcriptional upregulation of ENaC
subunits with another recent report suggesting that in-
creased Na+ absorption in the distal colon is directly cor-
related with transcriptional upregulation [20].
Nevertheless, other factors may be involved in colonic
Na+ and water transport besides the epithelial Na+ chan-
nels and transporters. In particular the barrier properties
of the pericryptal sheath are integral to colonic fluid trans-
port [1] and may play an important role in LS stimulated
fluid absorption.
LS diet, hyperaldosteronism, or high levels of angiotensin
II increase the amounts of fibrotic tissue in vascular tissue
like heart and surrounding arterioles [21,22]. This process
leads to myocardial hypertrophy and subsequent heart
failure. The primary cause of the increased myocardial fi-
brosis is invasion of the damaged tissue by macrophages
and transformation of fibroblasts into myofibroblasts.
Under the influence of AT II these cells produce cytokines,
transforming growth factor β , (TGF β ), endothelin 1, (ET-
1) and connective tissue growth factor, (CTGF) that stim-
ulate the myofibroblasts to generate collagen [23,24].
TGF-β  signalling occurs through its interaction with TGF-
β  type 1 and type II receptors. TGF-β  initially binds to the
type II receptor, which then recruits the type 1 receptor
into a large receptor complex and initiates a subsequent
signalling cascade [25,26]. AT II binding to myofibrob-
lasts in heart valves and the adventitia of coronary arteries
has been demonstrated with immunolabelling and auto-
radiography [22]. The coincidence of angiotensin convert-
ing enzyme activity and AT-II type 1 receptors has been
observed at sites of fibrosis and high-density angiotensin
converting enzyme (ACE) antibody binding has also been
observed at the site of myocardial infarction after one
week. TGF β  release by myofibroblasts leads to further re-
lease of cytokines by the myofibroblasts closing a positive
feedback loop. This in turn leads to overproduction of col-
lagen by the stimulated myofibroblasts.
This potentially pathological process can be modified
pharmacologically. Either angiotensin converting enzyme
inhibitors (ACEI), such as Captopril or Enalapril; or AT II
receptor type 1 antagonists (AT1Ra), such as Losartan, pre-
vent both the myocardial fibrosis following myocardial
infarction, or hypertension and can also induce regression
of fibrosis after it has developed [27]. A combination of
Losartan and ACEI prevents post-radiation renal fibrosis
induced uraemia in rats [28].
A LS diet has already been shown to increase the amounts
of E-cadherin, β -catenin and smooth muscle actin in the
pericryptal sheath cells of rat colon, thereby increasing its
strength and barrier properties [1].BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/4
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Radiation Fibrosis
Fibrosis is one of the major late effects of both radiother-
apy and accidental radiation exposure. Its major charac-
teristic is the massive over production and deposition of
extracellular matrix components. Fibrosis after radiation
has been described in numerous tissues including skin
[29], lung [30], heart [31], liver [32] and kidney [28]. In
the initial phase there is infiltration of inflammatory cells
and macrophages, numerous endothelial cells in neocap-
illaries and an abundance of myofibroblast cells
[3,33,34]. These 'activated fibroblasts' are thought to be
primarily involved in the deposition of extracellular ma-
trix.
In radiation fibrosis, it has been proposed that there is a
loss of regulation of myofibroblast proliferation leading
to the pathological increase in matrix deposition as a re-
sponse to chronic long-term activation of these cells. Im-
portant factors in the stimulation of the myofibroblasts to
produce matrix are various cytokines and growth factors.
Several of these including TGF-β , Platelet derived growth
factor (PDGF), Tumour Necrosis factor (TNF-α ), basic fi-
broblast growth factor (bFGF), Interleukin 1 and 4 (IL-1,
IL-4) and Connective tissue growth factor (CTGF) have
been found to be dysregulated in fibrotic lesions [35–37].
In particular the key role of TGF-β  was shown by the find-
ing of fibrosis in multiple organs including liver and kid-
ney in transgenic mice overexpressing TGF-β  [37]. Ang II,
as mentioned previously, has also been shown to play an
important role in fibrotic lesions.
Radiation fibrosis in the small intestine has been shown
to be associated with large increases in the amounts of
TGF-β 1, TGF-β 2 and TGF-β 3 both in epithelial and mes-
othelial cells [38] Radiation induced fibrosis has shown in
other tissues, such as kidney and skin. There is evidence
that myofibroblasts play a major role in this long term ef-
fect of radiation [33]. In Crohn's disease there are marked
increases in collagen type III and RNA transcripts for pro-
collagens I, III and IV [39].
ACE inhibitors
Angiotensin converting enzyme inhibitors (ACEI) have
been shown to be effective against radiation-induced fi-
brosis in the lung, heart and kidney. Originally ACEI, such
as Captopril and Lisinopril were shown to be effective in
reducing structural changes in the heart in hypertension
[40]. In radiation-induced fibrosis in the lung, Captopril
was effective in preventing pulmonary endothelial dys-
function and was also shown to reduce the accumulation
of collagen in the lung interstitium [41]. ACEI were simi-
larly found to ameliorate fibrosis in the heart [42], as well
as other indices, such as capillary function and the in-
crease in mast cells. It was shown both in the lung and the
kidney that radiation causes an increase in myofibroblasts
and that ACE inhibition prevented the proliferation of
these cells [28,43]. The mechanism of action of ACEI was
clarified by studies on lung radiation injury in which the
AT II receptor blocker, Losartan was shown to be as effec-
tive as ACE inhibition on reducing collagen synthesis
[44].
In this paper we demonstrate that a LS diet and radiation
damage increase the amounts of angiotensin converting
enzyme, AT II type 1 receptors, TGF-β  type1 receptor, col-
lagen IV and OB cadherin in the pericryptal sheaths of de-
scending colon and that the radiation induced effects can
be prevented by the ACEI, Captopril.
Materials and Methods
Confocal microscopy
The tissue was viewed using a Nikon Diaphot inverted mi-
croscope with Nikon Fluor 20 ×  and 60 ×  lenses. The mi-
croscope was attached to an MRC 600 confocal scanhead,
equipped with two detection channels and an Ar/Kr
mixed gas laser allowing excitation at 488 nm and 568
nm. Z-axis movement, with 0.1 µm resolution, was pro-
vided by software controlled stepper motor attached to
the fine focus control.
Low and High Na+ diet
In order to vary blood aldosterone levels, rats were fed on
LS and HS diets that are known to increase and decrease
respectively circulating aldosterone levels. The rats fed on
a LS diet received plain flour + 5% wheat bran with water
ad libitum for 10 days. Rats fed on a HS diet received the
flour and bran diet, as above, but isotonic saline was sub-
stituted for drinking water. The rats maintained a normal
weight gain during this period. The effects of the diets on
the circulating aldosterone were tested to determine
whether they conformed to previously demonstrated ef-
fects. Blood samples were obtained from portal venous
blood immediately after cervical dislocation.
The normal level of circulating aldosterone in Wistar rats
is 1500 ± 250 pM. The effect of the HS diet was to reduce
the aldosterone level to 805 ± 73 pM (n = 3) while the LS
diet raised the plasma aldosterone level to 3065 ± 573 pM
(n = 3), which was significantly different from the level
seen with the HS diet (P < 0.01, Students t-test). These
concentrations are within the range of those previously
observed with these dietary regimens. [1,45,46].
Irradiation procedure
Experiments were performed on male Wistar rats (315–
360 g) obtained from CERJ (LeGenest St Isle France)
which were housed, four per cage and kept under constant
temperature (21°C) with a 12:12 light: dark cycle. They
had free access to food (normal rat chow, 105UAR,
France) and water throughout the experimental period.BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/4
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During irradiation, rats were conscious and restrained in a
ventilated plexiglass tube placed perpendicular to the
beam axis and then turned on the horizontal axis to re-
ceive homogenous whole body irradiation. Animals were
irradiated once using a 60Co source at a dose of 8 Gy with
a dose rate of 0.75 Gy/min. Control animals were treated
in exactly the same manner but not exposed to the source
(sham-irradiation) and all were treated at the same time
of day.
Captopril treatment
Four experimental groups were included in the study;
Control rats, rats treated with Captopril, irradiated rats
and irradiated and Captopril treated rats. Treated rats were
given Captopril (125 mg/kg)/day) in their drinking water.
Tissue for immunocytochemistry was collected as before
and data analysis performed also as before.
Tissue preparation
For high/low Na+ experiments rats (Wistar) weighing
150–200 G were killed by cervical dislocation and the de-
scending colon and caecum were removed rapidly and the
contents removed by washing with buffer. Colonic muco-
sa was stripped of its muscle layer and fixed in 2% para-
formaldehyde in PBS at 37°C for 30 mins. The tissue was
washed and stored in PBS at 4°C.
For the radiation experiments animals were killed by cer-
vical dislocation at several time points (1, 2 and 3
months) after exposure to sham and radiation sources.
The distal colon was removed rapidly and the contents re-
moved by washing with buffer. Colonic mucosa was
stripped of its muscle layer and fixed in 2% paraformalde-
hyde in PBS at 37°C for 30 mins. The tissue was washed
and stored in PBS at 4°.
Immunocytochemistry
Colonic mucosal tissue (0.5 cm2 pieces) was placed in 1.5
ml Eppendorf tubes. The tissue was then stained accord-
ing to the following protocol. The procedure was the same
for all antibodies used. The tissue was permeabilised in
0.2% Triton X-100 in PBS for 30 mins. Samples were
washed twice in PBS and incubated in blocking buffer
(2% goat serum in PBS or 5% FCS) for 30 mins. The tissue
was then incubated for 60 mins with primary antibody
(1:100), washed 3×  in blocking buffer and then incubated
for 60 mins in each secondary antibody (1:100) and left
in blocking buffer.
Antibodies
The antibodies were obtained from the following agen-
cies: Chemicon: rabbit anti-AT II Type I receptor; mouse
anti-angiotensin converting enzyme (ACE) – mono-
clonal, RDI rabbit anti-collagen Type IV; Santa Cruz: goat
anti-OB cadherin (C-16), rabbit anti-TGF-β  Type I recep-
tor (R-20). For AT-1, TGF-β R1 and collagen IV stained tis-
sue, biotin anti-rabbit IgG was used as the secondary
antibody followed by Alexa-488 NeutrAvidin. For OB-
cadherin, biotin anti-goat IgG was used in combination
with Alexa-488 NeutrAvidin and for ACE staining Texas
Red goat anti-mouse IgG. All secondary antibodies and
Alexa-488 were obtained from Molecular Probes, Eugene
Oregon.
Confocal images
Each piece of tissue was viewed under the confocal micro-
scope using a Nikon 60× /1.4 na Plan Apochromat oil im-
mersion lens. The tissue was viewed from the mucosal
side. The focus plane was taken to the surface of the tissue
and images were captured at 10 µm steps down using the
automatic Z-step motor. Images were taken from 0 µm
down to 40 µm below the surface. The images that were
captured represented as much as possible the general level
of staining throughout the whole tissue and were captured
with the same optical conditions, gain and section size.
Image analysis
The captured images were analysed using the program
NIH image (Wayne Rasband, National Institutes of
Health, USA) to quantify the fluorescence from each anti-
body. The fluorescence was quantified by using the meas-
ure function in the program to give the mean grey level of
a designated area. The areas were divided into either crypt
or intercrypt and were taken by selecting a region of inter-
est within the relevant part of the image. Three areas of
both crypt and intercrypt were taken per image and there-
fore there were thirty measurements per tissue at the vari-
ous depths. Also one area per image was taken as a
background value. The mean and SEM of the measure-
ments after background subtraction from each image was
calculated. The average and SEM of the numbers at depths
of 20 µm and 30 µm were calculated and plotted. The his-
tograms were calculated after subtracting backgrounds
from conjugate controls with no first antibodies present.
Images at 0,10 and 40 µm were not analysed usually be-
cause the images close to the surface tend to show hetero-
geneous antibody staining and those below 40 µm tend to
become blurred.
Statistics
Estimates of statistical significance were obtained using
Student's t tests for paired data and one-way analysis of
variance (ANOVA).
All experiments concerning radiation were conducted ac-
cording to the French regulations for animal experimenta-
tion. Ministry of Agriculture Act No 87-848,19 October
1987 and all experiments on high and low Na+ diets were
carried out under Home Office Regulations in a fully su-BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/4
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pervised conditions within the animal house of King's
College.
Results
Effects of LS and HS diet on α -smooth muscle actin and 
OB cadherin antibody distribution in rat distal colon and 
caecum.
LS diet increases the amounts of OB cadherin (26.3% ±
12.4), and smooth muscle actin (82.5% ± 13.8) in the my-
ofibroblasts of the pericryptal sheath of descending colon
in comparison with the amounts found in HS dieted rats
(p < 0.05 and 0.001 respectively). There is no evidence of
any increase in either OB cadherin or smooth muscle actin
in caecal pericryptal sheath cells (Figure 1).
Additionally, there is very little staining for both of these
myofibroblast specific antigens in the caecum. These find-
ings confirm our previous finding that there is no signifi-
cant presence of a pericryptal barrier in caecum and that
this is unaffected by dietary Na+ intake [1].
Effects of LS and HS diet on AT-II receptor distribution, 
ACE, TGF-β R1 and collagen IV distribution in rat distal co-
lon and caecum.
Development of high density ACE, increases in AT II re-
ceptor and TGF-β  receptor density and increased rates of
synthesis by collagen are signs of activation of myofibrob-
lasts [21]. LS diet increases the density of ACE (70.1% ±
13.1), AT-II receptor density (135.6% ± 18.3), TGF-β  re-
ceptor density (291.0% ± 26.5) and collagen IV (49.6% ±
15.3) in the descending crypts of rat in comparison with
HS diet (p < 0.001 in all cases, (Figures 2 and 3). ACE, AT-
II receptor and collagen are all more abundant in descend-
ing colon than in caecum, both in HS and LS diet condi-
tions (p < 0.01).
No evidence of systematic increases in ACE, AT-II receptor
and collagen is found in rat caecal crypts with LS diet.
More AT-II receptor and ACE are present in caecal crypts
from HS diet than in caecal crypts from LS diet (p < 0.05).
However, no difference between high and LS dieted rats is
found in the amount of collagen in caecal crypts. We
therefore conclude that there is no evidence of activation
of caecal myofibroblasts following a LS diet.
There are significant amounts of TGF-β  receptor in the cae-
cum, which are increased after LS diet (p < 0.001). How-
ever, these TGF-β  receptors may be associated with
capillaries as there is much more extensive blood supply
in the caecum as compared to the descending colon [47].
We have observed that large proportion of the TGF-β  re-
ceptor staining in the caecum is co-localised with the vas-
cular adhesion molecule PECAM-1 (data not shown). This
indicates that unlike in the descending colon, the increas-
es in caecal TGF-β RI are largely associated with capillaries
and not with myofibroblasts. Recently it has been suggest-
ed that microvascular damage initiates gastrointestinal
damage by chemotherapy or radiation [48]. The results
here suggest that increased expression of TGF-β  receptor
on capillary endothelial cells may restore endothelial
function, at least in colon.
Effects of radiation and effect of ACEI treatment on 
growth of myofibroblasts and the pericryptal sheath.
General observations
During the acute radiation response (days 1–7) food in-
take was reduced most markedly from days 2–5 with a na-
dir (60% reduction) between days 2 and 3. After one week
irradiated animals ate as the controls. Captopril treatment
had no effect on food intake. Similarly, during this period
Figure 1BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/4
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animals lost weight and after one week were some 10%
lighter than the respective controls. There was no apparent
effect of Captopril treatment on weight loss. At 1, 2 and 3
months post-exposure, irrespective of treatment, irradiat-
ed animals never regained the same weight as controls
and weighed some 20% less at 3 months. In both the ve-
hicle- and Captopril-treated groups, circulating lym-
phocytes remained lower for up to 2 months post-
irradiation, whereas platelets returned to normal within 1
month. This is in agreement with Moulder and Fish who
showed that Captopril did not prevent acute Gl radiation-
induced damage [49].
One month post-irradiation there is a significant increase
in the amount of TGF-β  type 1 receptor in the descending
colon pericryptal sheath (Figure 4). This continues to two
months suggesting initial and continuing activation of the
pericryptal myofibroblasts. By 90 days, there is no signifi-
cant increase above control in TGF-β  receptor in irradiated
tissues. Further evidence for myofibroblast activation is
shown by the increases in α -smooth muscle actin particu-
larly in the 30–60 day period post-irradiation (Figure 5).
Previous work has shown [50] that there is a rapid recov-
ery of collagen IV associated with the pericryptal sheath af-
ter exposure to whole body ionising radiation. At day 4,
compared with control only 20% of the collagen IV is
present in the pericryptal sheaths of irradiated rats. By day
Figure 2
Figure 3BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/4
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10, collagen IV levels in irradiated colon have fully recov-
ered. During the next 3 months there is an increase in the
amount of collagen IV in the pericryptal sheaths of irradi-
ated animals that is not significantly above control until 3
months post-irradiation. This supports the view that in-
creased activity of pericryptal myofibroblasts leads to in-
creased deposition of collagen. Additionally, the increase
in TGF-β  type I receptor one month post-irradiation is
consistent with a TGF-β  mediated activation process.
The increases in collagen, smooth muscle actin and TGF-
β  receptor are all abolished by treatment of the animals
with Captopril, particularly at two months post-irradia-
tion. Captopril on its own also caused a reduction in
smooth muscle actin and TGF-β  receptor suggesting a
down-regulation of the myofibroblasts in control tissue
(Figure 6).
Discussion
Upregulation of AT-II and TGF-β  receptors in descending 
colonic mucosa: effects of LS and HS diet.
The presence of AT II type 1 receptors has been shown to
be a key factor in development of fibrosis in tissues like
heart, liver, lungs, kidney [27–32] and now in colon.
Without these receptors it is unlikely that myofibroblast
activation or its sequelae, namely increased ACE density at
the membrane surface and increased synthesis of collagen
by the cells, can occur. Collagen production requires the
myofibroblasts to be synergistically activated by AT II and
other growth factors, namely TGF-β  and CTGF [25,27].
To date no barrier function has been ascribed to the en-
hanced myofibroblast growth surrounding the capillaries
in heart, lung, liver or kidney; although this may well be
an important factor in the developing dysfunction of
Figure 4 Figure 5BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/4
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these organs. It has been shown that the formation of scar-
like epiretinal membranes is a result of TGF-β  induced
myofibroblast activation and may be related to the end
stage of diabetic retinopathy [51].
The density of TGF-β  type I receptors is significantly in-
creased in the descending colon of LS dieted rats specifi-
cally on myofibroblasts; indicating that it is TGF-β  in
conjunction with AT II that provides the trophic stimulus
for activation and subsequent collagen production. How-
ever, there are also significant levels of TGF-β 1 receptors in
the caecum, which are increased under LS diet. The lack of
a pericryptal sheath in the caecum as shown by the lack of
OB-cadherin and smooth muscle actin and the absence of
collagen deposition and ACE production would suggest
that TGF-β 1 receptors are not localised to myofibroblasts
at this site. The caecum has a much more extensive capil-
lary network than the descending colon [2] as shown by
the presence of the vascular endothelial adhesion mole-
cule PECAM-1. In the caecum, with both high and LS di-
ets, PECAM-1 is found co-localised with TGF-β 1 receptors,
suggesting that these receptors are up-regulated on capil-
laries [48,52] rather than myofibroblasts at this site.
The smooth muscle actin antigen is present in the peric-
ryptal sheath and is used as a marker of myofibroblasts. It
is increased in the pericryptal sheath cells of descending
colon in rats subjected to LS diet and present to a much
lesser extent in HS diet. OB-cadherin is a cadherin mainly
found in mesenchymal tissue [53–55] although a small
presence is found in descending colonic and caecal epi-
thelia. This may be due to some cross reactivity with other
cadherins raising the background levels in caecum and de-
scending colonic luminal epithelium.
Increase in ACE, and Collagen IV after LS diet
It is known that activation of myofibroblasts by AT II and
TGF-β  results in collagen synthesis and enhancement of
ACE activity at sites of collagen production [27,28]. Hence
an increase in collagen and ACE is to be expected at sites
of myofibroblast activation. This prediction is corroborat-
ed by our findings that both ACE and collagen are signifi-
cantly increased in the pericryptal sheath surrounding the
descending colon of LS dieted rats and virtually absent
from caecum in rats with either high or LS diet
Thus the increases in collagen IV, a product of myofibrob-
lasts; myofibroblast specific adhesion molecules (OB cad-
herin) and smooth muscle actin a cytoskeletal element
associated mainly with myofibroblasts, as previously
shown [1], are all consistent with a specific growth stimu-
lus to the pericryptal sheath cells.
Absence of myofibroblast activation in caecal mucosa.
An important factor in inferring the causal relationship
between development of the barrier function of the peric-
ryptal sheath and the absorptive function of descending
colonic crypts is the total absence of this relationship in
the caecal crypts of the same animals.
The caecum, unlike the descending colon is unable to ab-
sorb fluid from a high hydraulic resistance within its lu-
men. This has been related to the absence of any
significant pericryptal barrier, which is an essential com-
ponent of the crypts capacity to generate a hypertonic ab-
sorbate [1,2]. We have also shown recently that caecal
permeability to FITC dextran is much higher than the de-
scending colon providing further evidence for a lack of
barrier capacity in the caecal pericryptal space [5]. We
showed previously that smooth muscle actin, F-actin, E-
cadherin or β -catenin are virtually absent from the caecal
pericryptal sheath. In the present study we show that the
myofibroblast-specific adhesion molecule OB-cadherin
(also named cadherin 11) [53–55] is not up-regulated in
Figure 6BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/4
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caecal crypts by LS diet. Nor are any changes in the
amounts of collagen IV, ACE, or AT 1 receptor observed.
Despite the presence of AT1 receptors in caecum, no clear
increase in AT1 receptors is found with LS diet in caecum.
This may suggest that other growth factors are required be-
fore myofibroblastic and epithelial growth can be stimu-
lated. Alternatively, there may be factors that specifically
repress myofibroblastic activation within the caecum.
Long term response of pericryptal sheath after radiation
Myofibroblast cells have been implicated in fibrotic le-
sions in a number of different situations, including radio-
therapy of the abdomino-pelvic region [34]. In the lung,
it has been shown that radiation causes proliferation of
these cells in conjunction with increased collagen synthe-
sis [43,44]. The increases in smooth muscle actin, particu-
larly at two and three months (Figure 5) indicate that
there is proliferation of myofibroblasts in the pericryptal
sheath in descending colon. A number of different cy-
tokines have been implicated in intestinal fibrosis and
one of the most important of these is TGF-β . Increased lev-
els of TGF-β  have been clearly demonstrated in the small
intestine following both single and fractionated radiation
exposure suggesting a role of this cytokine in the patho-
genesis of both primary and consequential radiation en-
teropathy [56]. The present results show that the TGF-β
type 1 receptor is up-regulated at one to two months, (Fig-
ure 4). This strongly suggests increased levels of TGF-β  in
the colon, as has been shown in other fibrotic lesions
[35,44]. Increased amounts of the TGF-β  receptor local-
ized in the pericryptal sheath suggest that it is exerting lo-
cal effects on the myofibroblast cells. The increase in
smooth muscle actin, which occurs slightly after TGF-β  re-
ceptor upregulation, implies that TGF-β  induces myofi-
broblast differentiation and proliferation. TGF-β -induced
morphological and functional differentiation of myofi-
broblast cells resulting in increased smooth muscle actin
and stress fibres have previously been shown in cell cul-
ture [57].
The results also show that collagen type IV is increased at
three months post-irradiation, confirming previous stud-
ies showing marked increases in collagen at 3–6 months
post-irradiation [58]. The increase in collagen is preceded
by the increases in TGF-β  receptors and smooth muscle ac-
tin suggesting that one of the main stimuli driving the in-
crease in collagen is TGF-β  probably acting on the
myofibroblasts. It has been also been shown that neutral-
ization of endogenous TGF-β  inhibits increases colonic in
collagen [59].
The findings that TGF-β  receptors, smooth muscle actin
and collagen are increased during 1–3 month period post-
irradiation suggest that one of the major factors in the fi-
brotic process is cytokine-mediated activation of the my-
ofibroblasts. Fibrosis may be initiated by AT-ll-induced
changes, as is evident from the fact that the ACEI, Capto-
pril inhibits this process. This indicates that AT-II induced
events are an integral part of the fibrotic process.
Studies on lung fibrosis induced after radiation, suggests
that the anti-fibrotic effect of ACEI are directly related to
inhibition of AT-II synthesis, rather than other collateral
pharmacological properties, such as anti-oxidation or
protease inhibition [44].
An interesting aspect of the results is the fact that both in
unirradiated and irradiated tissues Captopril treatment
causes a reduction in expression of pericryptal sheath
structures with respect to untreated control tissues. This
suggests that colonic myofibroblasts, require constant
stimulation by cytokines to maintain their steady state
level of expression and that suppression of this stimulus
leads to down-regulation of myofibroblast synthesized
proteins e.g. collagen and ACE.
Both altered dietary Na+ and whole body irradiation re-
sult in marked changes in descending colon pericryptal
myofibroblasts. In LS dieted rats there is evidence of TGF-
β  and Angiotensin II mediated myofibroblast activation
resulting in extracellular matrix deposition. The same
process of cytokine mediated myofibroblast activation
also occurs after radiation, resulting in the increased
amounts of collagen, characteristic of post-irradiation fi-
brotic lesions. Pharmacological intervention with the ACE
inhibitor Captopril results in the inhibition of these
changes. This finding provides further evidence for an im-
portant modulatory role of Angiotensin II in colonic func-
tion and may be of use in the treatment of colonic fibrosis
post-irradiation.
TGF-β  mediated changes to myofibroblasts have been
shown in other tissues and in culture but have additional
importance in the descending colon due to the role of the
pericryptal sheath in fluid absorption.
Abbreviations
AT1 Angiotensin II type 1 receptor;
ACE Angiotensin converting enzyme;
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